Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.50 |
| ▸ | TRAP1 | Q12931 | 6/20 | 0.46 |
| ▸ | HSP90B1 | P14625 | 5/20 | 0.46 |
| ▸ | MGLL | Q99685 | 2/20 | 0.45 |
| ▸ | ABHD6 | Q9BV23 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6970630 | 0.99 | HRH3 (0.49) | HRH3TRAP1HSP90B1MGLLABHD6 | |
| SCHEMBL6970722 | 0.96 | HRH3 (0.55) | HRH3TRAP1HSP90B1MAOB | |
| SCHEMBL6969822 | 0.95 | HRH3 (0.54) | HRH3TRAP1HSP90B1MAOB | |
| SCHEMBL6967891 | 0.95 | TRAP1 (0.47) | HRH3TRAP1HSP90B1MGLLABHD6 | |
| SCHEMBL6967738 | 0.92 | TRAP1 (0.44) | HRH3TRAP1HSP90B1MGLLABHD6 | |
| SCHEMBL6970096 | 0.92 | HRH3 (0.49) | HRH3TRAP1HSP90B1MAOB | |
| SCHEMBL6970896 | 0.88 | TRAP1 (0.42) | HRH3TRAP1HSP90B1ABHD6MAOB | |
| SCHEMBL6970937 | 0.88 | TRAP1 (0.59) | HRH3TRAP1HSP90B1MGLLABHD6 | |
| SCHEMBL6968228 | 0.88 | MGLL (0.45) | HRH3TRAP1HSP90B1MGLLABHD6 | |
| SCHEMBL6970639 | 0.87 | TRAP1 (0.60) | HRH3TRAP1HSP90B1MGLLABHD6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8183279-B2 | 1,3-dihydroisoindole derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-05-22 | — | — | US | disclosed |
| US-8183279-B2 | 1,3-dihydroisoindole derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-05-22 | — | — | US | disclosed |
| US-20100311745-A1 | 1,3-DIHYDROISOINDOLE DERIVATIVES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-12-09 | — | — | US | disclosed |
| US-20100311745-A1 | 1,3-DIHYDROISOINDOLE DERIVATIVES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311745-A1 | 1,3-DIHYDROISOINDOLE DERIVATIVES | HSP90AB1, HSP90AA1, HSP90AB2P | HRH3 513/4885TRAP1 11/4885HSP90B1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.